Protagonist Therapeutics, Inc Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized
Protagonist Therapeutics, Inc (PTGX) reported Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized of $4.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized · last filed 2026-08-05
- Protagonist Therapeutics, Inc contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2026-06-30 was $4.40M, a 12.00% decline year-over-year.
- Protagonist Therapeutics, Inc contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2026-03-31 was $3.30M, a 40.00% decline year-over-year.
- Protagonist Therapeutics, Inc contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2025-09-30 was $4.70M, a 0.00% change year-over-year.
- Protagonist Therapeutics, Inc contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2025-06-30 was $5.00M, a 19.05% increase year-over-year.
| Period end | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 3 month | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 6 month | Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 9 month |
|---|---|---|---|
| 2026-06-30 | $4.40M 10-Q · filed 2026-08-05 | $7.60M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $3.30M 10-Q · filed 2026-05-05 | ||
| 2025-09-30 | $4.70M 10-Q · filed 2025-11-06 | $14.90M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.00M 10-Q · filed 2025-08-06 | $10.50M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $5.50M 10-Q · filed 2026-05-05 | ||
| 2024-09-30 | $4.70M 10-Q · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $4.20M 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | $900.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $900.00K 10-Q · filed 2022-08-04 | $900.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-04 | ||
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-08 | $1.70M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-04 | $1.50M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-05 | ||
| 2020-09-30 | $8.50M 10-Q · filed 2021-11-03 | $11.80M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $2.10M 10-Q · filed 2021-08-04 | $3.30M 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |